FDANews
FDAnews Device Daily Bulletin

Q CHIP, BIOCOMPATIBLES SEAL RESEARCH DEAL

Jan. 3, 2005

Cardiff, Wales-based Q Chip has signed a new research deal with Biocompatibles International, a medical device company focused on the treatment of cardiovascular disease, cancer and benign tumors.

The Welsh company possesses technology that enables the production of uniform particles at a molecular level, using tiny capillaries etched in wafers to precisely create micro- and nano-particles.

By using many of these wafers in tandem, the company can create particles on a commercial scale and avoid high levels of waste associated with other production techniques. The aim of the collaboration is to develop a new device for the production of Biocompatibles' next generation of microspheres. These would allow the effective delivery of drugs to targeted parts of the body.

(http://www.fdanews.com/pub/ddl)